Study of the interaction among Notch pathway receptors, correlation with stemness, as well as their interaction with CD44, dipeptidyl peptidase-IV, hepatocyte growth factor receptor and the SETMAR transferase, in colon cancer stem cells

References

• Artavanis-Tsakonas S, Rand MD, Lake RJ. Notch signaling: cell fate control and signal integration in development. Science 1999;284:770–6
   PubMed Web of Science ®Google Scholar
• Brou C, Logeat F, Gupta N, et al. A novel proteolytic cleavage involved in Notch signaling: the role of the disintegrin-metalloprotease TACE. Mol Cell 2000;5:207–16
   PubMed Web of Science ®Google Scholar
• Allenspach EJ, Maillard I, Aster JC, Pear WS. Notch signaling in cancer. Cancer Biol Ther 2002;1:466–76
   PubMed Web of Science ®Google Scholar
• Takebe N, Harris PJ, Warren RQ, Ivy SP. Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways. Nat Rev Clin Oncol 2011;8:97–106
   PubMed Web of Science ®Google Scholar
• Wu XZ. Origin of cancer stem cells: the role of self-renewal and differentiation. Ann Surg Oncol 2008;15:407–14
   PubMed Web of Science ®Google Scholar
• Liu HG, Chen C, Yang H, et al. Cancer stem cell subsets and their relationships. J Transl Med 2011;9:50
   Google Scholar
• Meng RD, Shelton CC, Li YM, et al. Gamma-Secretase inhibitors abrogate oxaliplatin-induced activation of the Notch-1 signaling pathway in colon cancer cells resulting in enhanced chemosensitivity. Cancer Res 2009;69:573–82
   PubMed Web of Science ®Google Scholar
• Hellstrom M, Phng LK, Hofmann JJ, et al. Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis. Nature 2007;445:776–80
   PubMed Web of Science ®Google Scholar
• Maillard I, Weng AP, Carpenter AC, et al. Mastermind critically regulates Notch-mediated lymphoid cell fate decisions. Blood 2004;104:1696–702
   PubMed Web of Science ®Google Scholar
• Chiou SH, Yu CC, Huang CY, et al. Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma. Clin Cancer Res 2008;14:4085–95
   PubMed Web of Science ®Google Scholar
• Pan G, Thomson JA. Nanog and transcriptional networks in embryonic stem cell pluripotency. Cell Res 2007;17:42–9
   PubMed Web of Science ®Google Scholar
• Rodda DJ, Chew JL, Lim LH, et al. Transcriptional regulation of nanog by OCT4 and SOX2. J Biol Chem 2005;280:24731–7
   PubMed Web of Science ®Google Scholar
• Yu DM, Yao TW, Chowdhury S, et al. The dipeptidyl peptidase IV family in cancer and cell biology. FEBS J 2010;277:1126–44
   PubMed Web of Science ®Google Scholar
• Su YJ, Lai HM, Chang YW, et al. Direct reprogramming of stem cell properties in colon cancer cells by CD44. EMBO J 2011;30:3186–99
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001;25:402–8
   PubMed Web of Science ®Google Scholar
• Wang Z, Li Y, Ahmad A, et al. Targeting Notch signaling pathway to overcome drug resistance for cancer therapy. Biochim Biophys Acta 2010;1806:258–67
   PubMed Web of Science ®Google Scholar
• Dievart A, Beaulieu N, Jolicoeur P. Involvement of Notch1 in the development of mouse mammary tumors. Oncogene 1999;18:5973–81
   PubMed Web of Science ®Google Scholar
• Wang Z, Zhang Y, Li Y, et al. Down-regulation of Notch-1 contributes to cell growth inhibition and apoptosis in pancreatic cancer cells. Mol Cancer Ther 2006;5:483–93
   PubMed Web of Science ®Google Scholar
• Ungerback J, Elander N, Grunberg J, et al. The Notch-2 gene is regulated by Wnt signaling in cultured colorectal cancer cells. PLoS One 2011;6:e17957
   Google Scholar
• Samejima H, Torii C, Kosaki R, et al. Screening for Alagille syndrome mutations in the JAG1 and NOTCH2 genes using denaturing high-performance liquid chromatography. Genet Test 2007;11:216–27
   Google Scholar
• Simpson MA, Irving MD, Asilmaz E, et al. Mutations in NOTCH2 cause Hajdu-Cheney syndrome, a disorder of severe and progressive bone loss. Nat Genet 2011;43:303–5
   PubMedGoogle Scholar
• Karlstrom H, Beatus P, Dannaeus K, et al. A CADASIL-mutated Notch 3 receptor exhibits impaired intracellular trafficking and maturation but normal ligand-induced signaling. Proc Natl Acad Sci U S A 2002;99:17119–24
   PubMedGoogle Scholar
• Tan ZX, Li FF, Qu YY, et al. Identification of a known mutation in Notch 3 in familiar CADASIL in China. PLoS One 2012;7:e36590
   Google Scholar
• Jung SG, Kwon YD, Song JA, et al. Prognostic significance of Notch 3 gene expression in ovarian serous carcinoma. Cancer Sci 2010;101:1977–83
   Google Scholar
• Lambert JC, Mann D, Harris J, et al. Association study of Notch 4 polymorphisms with Alzheimer's disease. J Neurol Neurosurg Psychiatry 2004;75:377–81
   Google Scholar
• Gaiano N, Fishell G. The role of notch in promoting glial and neural stem cell fates. Annu Rev Neurosci 2002;25:471–90
   PubMed Web of Science ®Google Scholar
• Hitoshi S, Alexson T, Tropepe V, et al. Notch pathway molecules are essential for the maintenance, but not the generation, of mammalian neural stem cells. Genes Dev 2002;16:846–58
   PubMed Web of Science ®Google Scholar
• Dontu G, Jackson KW, McNicholas E, et al. Role of Notch signaling in cell-fate determination of human mammary stem/progenitor cells. Breast Cancer Res 2004;6:R605–15
   PubMed Web of Science ®Google Scholar
• Wang Z, Ahmad A, Li Y, et al. Targeting notch to eradicate pancreatic cancer stem cells for cancer therapy. Anticancer Res 2011;31:1105–13
   PubMed Web of Science ®Google Scholar
• Ezeh UI, Turek PJ, Reijo RA, Clark AT. Human embryonic stem cell genes OCT4, NANOG, STELLAR, and GDF3 are expressed in both seminoma and breast carcinoma. Cancer 2005;104:2255–65
   PubMed Web of Science ®Google Scholar
• Pang R, Law WL, Chu AC, et al. A subpopulation of CD26+ cancer stem cells with metastatic capacity in human colorectal cancer. Cell Stem Cell 2010;6:603–15
   PubMed Web of Science ®Google Scholar
• Lakshman M, Subramaniam V, Rubenthiran U, Jothy S. CD44 promotes resistance to apoptosis in human colon cancer cells. Exp Mol Pathol 2004;77:18–25
   PubMed Web of Science ®Google Scholar
• Subramaniam V, Vincent IR, Gilakjan M, Jothy S. Suppression of human colon cancer tumors in nude mice by siRNA CD44 gene therapy. Exp Mol Pathol 2007;83:332–40
   PubMed Web of Science ®Google Scholar
• Stella MC, Trusolino L, Pennacchietti S, Comoglio PM. Negative feedback regulation of Met-dependent invasive growth by Notch. Mol Cell Biol 2005;25:3982–96
   PubMedGoogle Scholar
• van Leenders GJ, Sookhlall R, Teubel WJ, et al. Activation of c-MET induces a stem-like phenotype in human prostate cancer. PLoS One 2011;6:e26753
   Google Scholar
• Shaheen M, Williamson E, Nickoloff J, et al. Metnase/SETMAR: a domesticated primate transposase that enhances DNA repair, replication, and decatenation. Genetica 2010;138:559–66
   Google Scholar
• Wray J, Williamson EA, Chester S, et al. The transposase domain protein Metnase/SETMAR suppresses chromosomal translocations. Cancer Genet Cytogenet 2010;200:184–90
   PubMedGoogle Scholar
• Lee SH, Jeong EG, Yoo NJ. Mutational analysis of NOTCH1, 2, 3 and 4 genes in common solid cancers and acute leukemias. APMIS 2007;115:1357–63
   Google Scholar
• McGill MA, Dho SE, Weinmaster G, McGlade CJ. Numb regulates post-endocytic trafficking and degradation of Notch1. J Biol Chem 2009;284:26427–38
   PubMed Web of Science ®Google Scholar
• Stylianou S, Clarke RB, Brennan K. Aberrant activation of notch signaling in human breast cancer. Cancer Res 2006;66:1517–25
   PubMed Web of Science ®Google Scholar
• Qiao L, Wong BC. Role of Notch signaling in colorectal cancer. Carcinogenesis 2009;30:1979–86
   PubMed Web of Science ®Google Scholar